Cytokinetics Inc. buy The Goldman Sachs Group, Inc.
Start price
09.11.23
/
50%
€31.60
Target price
09.11.24
€46.68
Performance (%)
91.46%
Price
06.05.24
€60.50
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc. has seen massive gains of 91.46%. This prediction currently runs until 09.11.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 3.419% | 3.419% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€38.80
02.03.23
02.03.23
€45.28
02.03.24
02.03.24
71.39%
03.03.24
03.03.24